Internet-Delivered Cognitive Behavior Therapy for Anxiety and Depression Amongst French Canadians
NCT ID: NCT03043833
Last Updated: 2018-05-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
64 participants
INTERVENTIONAL
2017-01-18
2018-03-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The primary objective is to establish the clinical efficacy of a French-Canadian self-guided format version of the Wellbeing Course by conducting a randomized-control trial where an experimental group will be compared to a waitlist control group. A secondary objective is to demonstrate the course's acceptability through participants' satisfaction with the course.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Online Cognitive Behaviour Therapy for Depression and Anxiety: Randomized Controlled Trial Varying Treatment Content
NCT03684434
Therapist-guided Internet-delivered Cognitive Behavioural Therapy
NCT03304392
Internet-delivered Cognitive Behaviour Therapy for Students: Duration Preference Trial
NCT05333627
Internet-based Cognitive Behavioural Therapy for Cardiac Patients
NCT04053244
Therapeutic Moderators of Therapist-assisted Internet-delivered Cognitive Behavior Therapy
NCT03957330
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Wellbeing Course
Will receive the French-Canadian version of the Wellbeing Course consisting of five lessons based on cognitive behavior therapy delivered through the Internet over eight weeks.
The Wellbeing Course
The Wellbeing Course (Titov et al., 2011) includes five online lessons:
* Lesson 1 presents information on the prevalence of anxiety disorders and depression as well as on how they may interfere with life goals. This lesson also discusses how cognitive, behavioral and physical symptoms can contribute to poor emotional health.
* Lesson 2 presents different strategies to generate realistic cognitions.
* Lesson 3 describes strategies for physical de-arousal and for re-engaging in reinforcing activities.
* Lesson 4 describes avoidance and safety behaviors in relation with anxiety and depression along with graded exposure.
* Lesson 5 is about problem solving, relapse prevention and staying well.
For each lesson, a "Do It Yourself" guide is included as well vignettes and additional material.
Waitlist-control
The Waitlist Control Group will receive the French-Canadian version of the Wellbeing Course once the treatment group will have completed treatment.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
The Wellbeing Course
The Wellbeing Course (Titov et al., 2011) includes five online lessons:
* Lesson 1 presents information on the prevalence of anxiety disorders and depression as well as on how they may interfere with life goals. This lesson also discusses how cognitive, behavioral and physical symptoms can contribute to poor emotional health.
* Lesson 2 presents different strategies to generate realistic cognitions.
* Lesson 3 describes strategies for physical de-arousal and for re-engaging in reinforcing activities.
* Lesson 4 describes avoidance and safety behaviors in relation with anxiety and depression along with graded exposure.
* Lesson 5 is about problem solving, relapse prevention and staying well.
For each lesson, a "Do It Yourself" guide is included as well vignettes and additional material.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Having identified French as the first official language spoken and having good reading comprehension in French.
* Reliable Internet access
* Clinically significant levels of depression or anxiety reflected by significant scores on the following measures: PHQ-9 \> 9, GAD-7 \>7, Penn Stage Worry Questionnaire ≥ 45, Social Phobia Inventory ≥ 19, Panic and Agoraphobia Scale ≥ 19, or by answering yes to the question "Is anxiety or low mood a problem for you"
* Not currently participating in cognitive-behavioral therapy
* No changes in medication for 4 weeks prior to the study, nor any changes in medication for the next 2 months
* Willing to disclose personal information
Exclusion Criteria
* Presence of severe depression as indicated by scores ≥ 23 on the PHQ-9, or a score \> 2 on item 9 of the PHQ-9
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Macquarie University, Australia
OTHER
Universite de Moncton
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
France Talbot
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
France Talbot, Ph.D.
Role: STUDY_DIRECTOR
Université de Moncton
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Université de Moncton - Adult Clinical Psychology Laboratory
Moncton, New Brunswick, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
File 1516-077
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.